Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case–Control Study

Graham Mazereeuw, Tara Gomes, Erin M. Macdonald, Simon Greaves, Ping Li, Muhammad M. Mamdani, Donald A. Redelmeier and David N. Juurlink ()
Additional contact information
Graham Mazereeuw: University of Toronto
Tara Gomes: Li Ka Shing Knowledge Institute
Erin M. Macdonald: The Institute for Clinical Evaluative Sciences
Simon Greaves: The Institute for Clinical Evaluative Sciences
Ping Li: The Institute for Clinical Evaluative Sciences
Muhammad M. Mamdani: Li Ka Shing Centre for Healthcare Analytics Research and Training
Donald A. Redelmeier: Sunnybrook Research Institute
David N. Juurlink: The Institute for Clinical Evaluative Sciences

Drug Safety, 2020, vol. 43, issue 8, No 5, 737-743

Abstract: Abstract Introduction Opioids have been increasingly associated with suicide, but whether they are independent contributors is unclear. Oxycodone and hydromorphone are commonly prescribed high-potency opioids that can differentially affect mood. Objective The objective of this study was to explore whether oxycodone and hydromorphone are differentially associated with suicide. Methods We conducted a retrospective population-based case-control study in Ontario, Canada, from 1992 to 2014. Using coronial data, we defined case subjects as individuals who died by suicide involving an opioid overdose. Each of these was matched with up to four controls who died of accidental opioid overdose. We ascertained exposure to oxycodone, hydromorphone, and other opioids from postmortem toxicology testing. We used odds ratios and 95% confidence intervals to examine whether opioid-related suicide was disproportionately associated with oxycodone relative to hydromorphone. Results We identified 438 suicides and 1212 accidental deaths, each of which involved either oxycodone or hydromorphone but not both. The median age at death was 49 years and 51% were men. After adjusting for a history of self-harm, psychiatric illness, and exposure to other opioids, we found that oxycodone was more strongly associated with suicide than hydromorphone (adjusted odds ratio 1.59; 95% confidence interval 1.20–2.11). In a secondary analysis, we observed a trend of similar magnitude in which combined exposure to oxycodone and hydromorphone was more strongly associated with suicide than hydromorphone alone (adjusted odds ratio 1.68; 95% confidence interval 0.92–3.09). Conclusions While preliminary, these findings support the possibility that some high-potency opioids might independently influence the risk of suicide in susceptible individuals.

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-020-00924-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00924-5

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-020-00924-5

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().